AstriVax

AstriVax NV, established in 2022, aims to address global vaccine challenges through its innovative plug-and-play vaccine platform. The company has developed novel preventive and therapeutic vaccines that are easy to produce, reduce cold chain requirements, and provide broad and long-lasting protection against various infectious diseases.